Annual Current Liabilities
$56.31 M
+$28.74 M+104.21%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual total current liabilities is $56.31 million, with the most recent change of +$28.74 million (+104.21%) on December 31, 2023.
- During the last 3 years, INBX annual current liabilities has risen by +$24.91 million (+79.34%).
- INBX annual current liabilities is now at all-time high.
Performance
INBX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$44.09 M
+$5.04 M+12.91%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly total current liabilities is $44.09 million, with the most recent change of +$5.04 million (+12.91%) on September 30, 2024.
- Over the past year, INBX quarterly current liabilities has increased by +$5.04 million (+12.91%).
- INBX quarterly current liabilities is now at all-time high.
Performance
INBX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
INBX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +104.2% | +12.9% |
| 3 y3 years | +79.3% | +35.1% |
| 5 y5 years | +248.0% | +35.1% |
INBX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +150.8% | at high | +119.3% |
| 5 y | 5-year | at high | +173.8% | at high | +119.3% |
| alltime | all time | at high | +531.3% | at high | +197.5% |
Inhibrx Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.09 M(+12.9%) |
| Jun 2024 | - | $39.05 M(+1.6%) |
| Mar 2024 | - | $38.43 M(+16.9%) |
| Dec 2023 | $56.31 M(+104.2%) | $32.86 M(-8.1%) |
| Sep 2023 | - | $35.77 M(+14.2%) |
| Jun 2023 | - | $31.33 M(-4.0%) |
| Mar 2023 | - | $32.64 M(+18.4%) |
| Dec 2022 | $27.58 M(+22.8%) | $27.58 M(+8.5%) |
| Sep 2022 | - | $25.43 M(+5.1%) |
| Jun 2022 | - | $24.20 M(+20.4%) |
| Mar 2022 | - | $20.11 M(-10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $22.45 M(-28.5%) | $22.45 M(-10.7%) |
| Sep 2021 | - | $25.15 M(+16.0%) |
| Jun 2021 | - | $21.67 M(-22.2%) |
| Mar 2021 | - | $27.85 M(-11.3%) |
| Dec 2020 | $31.40 M(+52.6%) | $31.40 M(-9.6%) |
| Sep 2020 | - | $34.74 M(+16.7%) |
| Jun 2020 | - | $29.77 M(+44.7%) |
| Dec 2019 | $20.57 M(+27.1%) | $20.57 M(+38.8%) |
| Jun 2019 | - | $14.82 M(-15.6%) |
| Mar 2019 | - | $17.56 M |
| Dec 2018 | $16.18 M(+81.4%) | - |
| Dec 2017 | $8.92 M | - |
FAQ
- What is Inhibrx Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual current liabilities year-on-year change?
- What is Inhibrx Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly current liabilities year-on-year change?
What is Inhibrx Biosciences annual total current liabilities?
The current annual current liabilities of INBX is $56.31 M
What is the all time high annual current liabilities for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual total current liabilities is $56.31 M
What is Inhibrx Biosciences annual current liabilities year-on-year change?
Over the past year, INBX annual total current liabilities has changed by +$28.74 M (+104.21%)
What is Inhibrx Biosciences quarterly total current liabilities?
The current quarterly current liabilities of INBX is $44.09 M
What is the all time high quarterly current liabilities for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly total current liabilities is $44.09 M
What is Inhibrx Biosciences quarterly current liabilities year-on-year change?
Over the past year, INBX quarterly total current liabilities has changed by +$5.04 M (+12.91%)